Free Trial

BeyondSpring (NASDAQ:BYSI) Shares Down 1.4% - Here's Why

BeyondSpring logo with Medical background

BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) shares traded down 1.4% during mid-day trading on Friday . The stock traded as low as $1.71 and last traded at $1.71. 4,718 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 15,068 shares. The stock had previously closed at $1.74.

BeyondSpring Stock Down 1.4 %

The company's fifty day moving average is $1.69 and its 200 day moving average is $1.96.

Institutional Trading of BeyondSpring

A hedge fund recently bought a new stake in BeyondSpring stock. Renaissance Technologies LLC bought a new stake in BeyondSpring Inc. (NASDAQ:BYSI - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,500 shares of the company's stock, valued at approximately $30,000. Institutional investors own 40.29% of the company's stock.

BeyondSpring Company Profile

(Get Free Report)

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BeyondSpring Right Now?

Before you consider BeyondSpring, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.

While BeyondSpring currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines